# Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

> **NCT06159842** · PHASE2 · COMPLETED · sponsor: **The Center for Clinical and Cosmetic Research** · enrollment: 32 (actual)

## Conditions studied

- Facial Cutaneous Squamous Cell Carcinoma in Situ

## Interventions

- **COMBINATION_PRODUCT:** Aminolevulinic Acid 20% Topical Solution with Blue Light

## Key facts

- **NCT ID:** NCT06159842
- **Lead sponsor:** The Center for Clinical and Cosmetic Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-08
- **Primary completion:** 2024-09-11
- **Final completion:** 2024-11-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06159842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06159842, "Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06159842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*